Moreover, the conversion of non-stem cancer cells to CSCs, such as in the case of trastuzumab resistance resulting in CSC proliferation, occurs predominantly as a result of IL-6 release by CSCs in the tumor microenvironment. The gene discussed is IL6; the disease is neoplasm.